United States: An Estimate Is Just That - The Seventh Circuit Highlights Several Important Lessons For Employers Navigating Intermittent FMLA Leave

Last Updated: August 22 2014
Article by Michael G. Congiu and Carly J. Zuba

The U.S. Court of Appeals for the Seventh Circuit recently ruled on two important intermittent Family and Medical Leave Act (FMLA) leave issues in Hansen v. Fincantieri Marine Group.1 First, the court determined that the FMLA does not require a plaintiff to present expert testimony to prove he was incapacitated for each day for which he requested FMLA leave.  Second – and perhaps more important for employers – the court decided that an employer should not summarily deny intermittent FMLA leave when an eligible employee exceeds the estimated length or duration provided by a doctor in an FMLA medical certification form.  

This ruling should inform employers within the Seventh Circuit regarding the appropriate response to employees whose absences exceed the estimated frequency and duration of incapacity listed on their medical certification forms.  The FMLA regulations authorize an employer to request recertification at any time if "[c]ircumstances described by the previous certification have changed significantly (e.g., the duration or frequency of the absence ...)."2 Hansen reinforces the need for employers to seek FMLA recertification where conditions appear to have considerably changed rather than take adverse action against an employee who has exceeded his or her certified leave.  Hansen further underscores the need for employers to work closely with their third-party leave administrators when making leave determinations that may lead to adverse actions. 

Facts of the Case

Fincantieri Marine Group (FMG or "the employer") employed the plaintiff as a shipbuilder. The plaintiff suffered from depression, and provided medical certification to FMG from his physician, stating that the plaintiff had a condition that would cause episodic flare-ups that prevented him from performing his job functions.  The doctor estimated the duration of the condition was "months," the frequency of flare-ups was four episodes every six months, and the duration of the related incapacity was two to five days.  

After the plaintiff requested FMLA leave for an absence in connection with his eighth episode in a matter of about two months, the employer's third-party administrator3 (TPA) sent the plaintiff's doctor a fax, indicating his latest absence was "out of his frequency and duration. Please confirm item #7."  Item #7 on the medical certification form asked about the plaintiff's need to attend follow-up appointments or work part-time or on a reduced schedule because of the plaintiff's condition.  The court assumed that the TPA intended to seek confirmation about Item #8 on the certification form, which asked about the estimated frequency and duration of episodic flare-ups and the duration of the incapacity.  The plaintiff's doctor faxed back "Item #7 confirmed" to the TPA.  Therefore, the TPA denied the plaintiff's request for FMLA leave since it believed his "[f]requency [was] exceeded."  

Over the following few weeks, the plaintiff requested, but was denied, additional days of FMLA leave in connection with his flare-ups.  The employer had an attendance policy whereby employees accumulate points for unexcused absences from work.  Eventually, the plaintiff exceeded the allotted points for unexcused absences, so the company terminated his employment for violating its attendance policy.  The plaintiff then sued under the FMLA, alleging claims of interference and retaliation.  

The employer argued the plaintiff was not entitled to FMLA leave for his absences because he significantly exceeded the estimated frequency in his doctor's medical certification, and moved for summary judgment on that basis.  The district court found that, while it appeared the plaintiff was taking off more time than was medically necessary, it was not so clear as to justify summary judgment.  The employer moved for reconsideration of its motion shortly before trial, arguing this time that the plaintiff needed expert medical testimony to establish he was incapacitated due to his serious health condition during the absences in which he was denied FMLA leave.  The district court ultimately agreed with the employer and concluded expert medical testimony was in fact required to prove that the plaintiff's serious health condition rendered him unable to perform the functions of his job during the absences, and granted summary judgment to the employer.     

The Seventh Circuit Opinion

The Seventh Circuit, however, reversed that decision.  The court decided that, while a plaintiff needs some medical evidence to establish a serious health condition, a plaintiff does not need expert testimony to establish incapacity where the employee suffers from a chronic condition like depression.  The court pointed out that the FMLA regulations addressing "continuing treatment" and "intermittent leave or reduced leave schedules" actually anticipate that the determination whether an employee cannot work due to a serious health condition would not necessarily be made by a medical professional.  The "continuing treatment" regulation provides that "[a]bsences attributable to incapacity ... [due to a chronic serious health condition] qualify for FMLA leave even though the employee ... does not receive treatment from a health care provider during the absence."4 And the "intermittent leave" regulation similarly provides that "[i]ntermittent ... leave may be taken for absences where the employee ... is incapacitated or unable to perform the essential functions of the positions because of a chronic serious health condition ... even if he or she does not receive treatment by a health care provider."5

The Seventh Circuit ruled also that the TPA's denial of the plaintiff's FMLA leave because his absences exceeded his doctor's estimates in the medical certification was improper.  The court explained that "[a]n estimate, by definition is not exact and cannot be treated as a certain and precise schedule."  To support this premise, the court relied on the existence of the recertification process, reasoning that, if the certified frequency and duration were hard limits on an employee's entitlement to leave, there would be no need to request recertification when an employee's requested leave exceeded the frequency or duration stated in the certification.  When the plaintiff's absences exceeded the frequency of the flare-ups and duration of related incapacity estimated in the certification, the employer should have sought recertification instead of simply denying leave. The Seventh Circuit explained that, as part of that recertification, the employer could have asked the plaintiff's doctor whether the plaintiff's condition and the need for leave were consistent with the frequency and duration of his absences, but the employer failed to do this.  The court found that the TPA's fax to the plaintiff's doctor asking him to confirm the prior certification was not a recertification; it did not request certification for the absences that exceeded the estimated frequency and duration.  Further, the court noted the fax was improper for other reasons: there was no evidence that the TPA gave the plaintiff notice of its faxed communication to his doctor, and the regulations prevent an employer from communicating directly with the employee's health care provider. 

Three Important Lessons for Employers

The Hansen decision highlights three important lessons for employers to keep in mind while navigating the treacherous waters of intermittent FMLA leave: 

  1. Where the frequency or duration of an eligible employee's absences changes substantially, the recertification process is the safest means to understand whether the employee's continued need for leave is legitimate.  The FMLA regulations permit employers to provide the employee's doctor with a record of the absences and inquire whether the employee's serious health condition and need for leave is consistent with the pattern of absences. 
  2. When seeking recertification from a physician, keep in mind that there are certain procedural requirements employers must adhere to throughout the process. For example: 
  • Be wary of seeking recertification too early, such as when an employee is only a couple of absences over the doctor's estimate in the medical certification.  The general rule is that an employer may require recertification no more than every 30 days and only in connection with an employee's absence.  If a certification indicates that the minimum duration of the serious health condition is more than 30 days, the employer must generally wait until that minimum duration expires before requiring recertification.  In all cases, an employer may request a recertification of a medical condition every six months in connection with an employee's absence.  However, an employer may request a recertification in less than 30 days if:

    • The employee requests an extension of leave;
    • The circumstances described by the previous certification have changed significantly; or
    • The employer receives information that causes it to doubt the employee's stated reason for the absence or the continuing validity of the certification.
  • Employers (and their TPAs) are generally prohibited from directly contacting an employee's health care provider, except where the employer seeks clarification/authentication of the medical certification and has first given the employee an opportunity to cure any deficiencies in the medical certification. 
  1. It is important to analyze carefully the actions that a TPA is taking in the face of particularly difficult FMLA and other leave of absence scenarios. To be sure, recertification processes should be reviewed with employment counsel to guarantee proper compliance with the FMLA.    


1 No. 13-3391.

2 29 C.F.R. § 825.308(c)(2).

3 The third-party administrator managed FMG's attendance policy.

4 29 C.F.R. § 825.115(f) (emphasis added).

5 29 C.F.R. § 825.202(b)(2) (emphasis added).

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

To print this article, all you need is to be registered on Mondaq.com.

Click to Login as an existing user or Register so you can print this article.

Michael G. Congiu
Carly J. Zuba
In association with
Related Video
Up-coming Events Search
Font Size:
Mondaq on Twitter
Register for Access and our Free Biweekly Alert for
This service is completely free. Access 250,000 archived articles from 100+ countries and get a personalised email twice a week covering developments (and yes, our lawyers like to think you’ve read our Disclaimer).
Email Address
Company Name
Confirm Password
Mondaq Topics -- Select your Interests
 Law Performance
 Law Practice
 Media & IT
 Real Estate
 Wealth Mgt
Asia Pacific
European Union
Latin America
Middle East
United States
Worldwide Updates
Check to state you have read and
agree to our Terms and Conditions

Terms & Conditions and Privacy Statement

Mondaq.com (the Website) is owned and managed by Mondaq Ltd and as a user you are granted a non-exclusive, revocable license to access the Website under its terms and conditions of use. Your use of the Website constitutes your agreement to the following terms and conditions of use. Mondaq Ltd may terminate your use of the Website if you are in breach of these terms and conditions or if Mondaq Ltd decides to terminate your license of use for whatever reason.

Use of www.mondaq.com

You may use the Website but are required to register as a user if you wish to read the full text of the content and articles available (the Content). You may not modify, publish, transmit, transfer or sell, reproduce, create derivative works from, distribute, perform, link, display, or in any way exploit any of the Content, in whole or in part, except as expressly permitted in these terms & conditions or with the prior written consent of Mondaq Ltd. You may not use electronic or other means to extract details or information about Mondaq.com’s content, users or contributors in order to offer them any services or products which compete directly or indirectly with Mondaq Ltd’s services and products.


Mondaq Ltd and/or its respective suppliers make no representations about the suitability of the information contained in the documents and related graphics published on this server for any purpose. All such documents and related graphics are provided "as is" without warranty of any kind. Mondaq Ltd and/or its respective suppliers hereby disclaim all warranties and conditions with regard to this information, including all implied warranties and conditions of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Mondaq Ltd and/or its respective suppliers be liable for any special, indirect or consequential damages or any damages whatsoever resulting from loss of use, data or profits, whether in an action of contract, negligence or other tortious action, arising out of or in connection with the use or performance of information available from this server.

The documents and related graphics published on this server could include technical inaccuracies or typographical errors. Changes are periodically added to the information herein. Mondaq Ltd and/or its respective suppliers may make improvements and/or changes in the product(s) and/or the program(s) described herein at any time.


Mondaq Ltd requires you to register and provide information that personally identifies you, including what sort of information you are interested in, for three primary purposes:

  • To allow you to personalize the Mondaq websites you are visiting.
  • To enable features such as password reminder, newsletter alerts, email a colleague, and linking from Mondaq (and its affiliate sites) to your website.
  • To produce demographic feedback for our information providers who provide information free for your use.

Mondaq (and its affiliate sites) do not sell or provide your details to third parties other than information providers. The reason we provide our information providers with this information is so that they can measure the response their articles are receiving and provide you with information about their products and services.

If you do not want us to provide your name and email address you may opt out by clicking here .

If you do not wish to receive any future announcements of products and services offered by Mondaq by clicking here .

Information Collection and Use

We require site users to register with Mondaq (and its affiliate sites) to view the free information on the site. We also collect information from our users at several different points on the websites: this is so that we can customise the sites according to individual usage, provide 'session-aware' functionality, and ensure that content is acquired and developed appropriately. This gives us an overall picture of our user profiles, which in turn shows to our Editorial Contributors the type of person they are reaching by posting articles on Mondaq (and its affiliate sites) – meaning more free content for registered users.

We are only able to provide the material on the Mondaq (and its affiliate sites) site free to site visitors because we can pass on information about the pages that users are viewing and the personal information users provide to us (e.g. email addresses) to reputable contributing firms such as law firms who author those pages. We do not sell or rent information to anyone else other than the authors of those pages, who may change from time to time. Should you wish us not to disclose your details to any of these parties, please tick the box above or tick the box marked "Opt out of Registration Information Disclosure" on the Your Profile page. We and our author organisations may only contact you via email or other means if you allow us to do so. Users can opt out of contact when they register on the site, or send an email to unsubscribe@mondaq.com with “no disclosure” in the subject heading

Mondaq News Alerts

In order to receive Mondaq News Alerts, users have to complete a separate registration form. This is a personalised service where users choose regions and topics of interest and we send it only to those users who have requested it. Users can stop receiving these Alerts by going to the Mondaq News Alerts page and deselecting all interest areas. In the same way users can amend their personal preferences to add or remove subject areas.


A cookie is a small text file written to a user’s hard drive that contains an identifying user number. The cookies do not contain any personal information about users. We use the cookie so users do not have to log in every time they use the service and the cookie will automatically expire if you do not visit the Mondaq website (or its affiliate sites) for 12 months. We also use the cookie to personalise a user's experience of the site (for example to show information specific to a user's region). As the Mondaq sites are fully personalised and cookies are essential to its core technology the site will function unpredictably with browsers that do not support cookies - or where cookies are disabled (in these circumstances we advise you to attempt to locate the information you require elsewhere on the web). However if you are concerned about the presence of a Mondaq cookie on your machine you can also choose to expire the cookie immediately (remove it) by selecting the 'Log Off' menu option as the last thing you do when you use the site.

Some of our business partners may use cookies on our site (for example, advertisers). However, we have no access to or control over these cookies and we are not aware of any at present that do so.

Log Files

We use IP addresses to analyse trends, administer the site, track movement, and gather broad demographic information for aggregate use. IP addresses are not linked to personally identifiable information.


This web site contains links to other sites. Please be aware that Mondaq (or its affiliate sites) are not responsible for the privacy practices of such other sites. We encourage our users to be aware when they leave our site and to read the privacy statements of these third party sites. This privacy statement applies solely to information collected by this Web site.

Surveys & Contests

From time-to-time our site requests information from users via surveys or contests. Participation in these surveys or contests is completely voluntary and the user therefore has a choice whether or not to disclose any information requested. Information requested may include contact information (such as name and delivery address), and demographic information (such as postcode, age level). Contact information will be used to notify the winners and award prizes. Survey information will be used for purposes of monitoring or improving the functionality of the site.


If a user elects to use our referral service for informing a friend about our site, we ask them for the friend’s name and email address. Mondaq stores this information and may contact the friend to invite them to register with Mondaq, but they will not be contacted more than once. The friend may contact Mondaq to request the removal of this information from our database.


From time to time Mondaq may send you emails promoting Mondaq services including new services. You may opt out of receiving such emails by clicking below.

*** If you do not wish to receive any future announcements of services offered by Mondaq you may opt out by clicking here .


This website takes every reasonable precaution to protect our users’ information. When users submit sensitive information via the website, your information is protected using firewalls and other security technology. If you have any questions about the security at our website, you can send an email to webmaster@mondaq.com.

Correcting/Updating Personal Information

If a user’s personally identifiable information changes (such as postcode), or if a user no longer desires our service, we will endeavour to provide a way to correct, update or remove that user’s personal data provided to us. This can usually be done at the “Your Profile” page or by sending an email to EditorialAdvisor@mondaq.com.

Notification of Changes

If we decide to change our Terms & Conditions or Privacy Policy, we will post those changes on our site so our users are always aware of what information we collect, how we use it, and under what circumstances, if any, we disclose it. If at any point we decide to use personally identifiable information in a manner different from that stated at the time it was collected, we will notify users by way of an email. Users will have a choice as to whether or not we use their information in this different manner. We will use information in accordance with the privacy policy under which the information was collected.

How to contact Mondaq

You can contact us with comments or queries at enquiries@mondaq.com.

If for some reason you believe Mondaq Ltd. has not adhered to these principles, please notify us by e-mail at problems@mondaq.com and we will use commercially reasonable efforts to determine and correct the problem promptly.